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SLIMEr: probing flexibility of lipid
metabolism in yeast with an improved
constraint-based modeling framework
Benjamín J. Sánchez1,2, Feiran Li1,2, Eduard J. Kerkhoven1,2 and Jens Nielsen1,2,3*
Abstract
Background: A recurrent problem in genome-scale metabolic models (GEMs) is to correctly represent lipids as
biomass requirements, due to the numerous of possible combinations of individual lipid species and the
corresponding lack of fully detailed data. In this study we present SLIMEr, a formalism for correctly representing
lipid requirements in GEMs using commonly available experimental data.
Results: SLIMEr enhances a GEM with mathematical constructs where we Split Lipids Into Measurable Entities
(SLIME reactions), in addition to constraints on both the lipid classes and the acyl chain distribution. By
implementing SLIMEr on the consensus GEM of Saccharomyces cerevisiae, we can represent accurate amounts of
lipid species, analyze the flexibility of the resulting distribution, and compute the energy costs of moving from one
metabolic state to another.
Conclusions: The approach shows potential for better understanding lipid metabolism in yeast under different
conditions. SLIMEr is freely available at https://github.com/SysBioChalmers/SLIMEr.
Keywords: Genome-scale metabolic modeling, Saccharomyces cerevisiae, Lipidomics, Flux balance analysis
Background
Genome scale metabolic models (GEMs) are widely used
to model and compute functional states of cellular
metabolism [1] and as scaffolds for integrating various
levels of high-throughput data [2]. A crucial step for
achieving proper simulations with GEMs is to define a
biomass pseudo-reaction [3, 4], which accounts for every
single constituent comprising the cellular biomass (pro-
teins, carbohydrates, lipids, etc.). In this step it is chal-
lenging to account for lipid requirements, as there are
copious different individual lipid species: over 20 differ-
ent classes of lipids can be produced in a cell, and each
specific lipid belonging to any of those classes can
contain various combinations of acyl chain groups, each
of them with varying length and number of saturations
[5]. This can yield over 1000 specific lipid species that
the cell can potentially produce. Unsurprisingly, lipid
metabolism therefore tends to be the most complicated
part of any GEM.
A requirement for formulating the biomass pseudo-re-
action are abundance measurements of every single con-
stituent; however, this is seldom available for individual
lipid species. Instead, it is more common to measure
separately (i) a profile of all different lipid classes, for
example by high-performance liquid chromatography [6,
7]; and (ii) a distribution of all different acyl chains, by
fatty acid methyl ester (FAME) analysis [8, 9]. Therefore,
GEMs have been adapted to handle these data.
The most common approach to represent lipid metab-
olism in GEMs is to enforce a specific distribution of
each individual lipid species, either by using detailed ex-
perimental data [10, 11] or by assuming that lipid classes
have all the same acyl chain distribution from a single
FAME analysis [12, 13]. In both cases however, the
model will be fixed to follow a predefined lipid distribu-
tion. This is undesirable, as lipid metabolism can show a
high level of reorganization [5, 14], hence rendering the
model’s predictions of limited use when simulating
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different experimental conditions, or when looking into
the network’s flexibility for satisfying lipid requirements.
A second common approach is to allow any specific
lipid to form a corresponding generic lipid class (e.g.,
“phosphocholine”) and to only constrain those classes
with experimental abundances from lipid profiling [15,
16]. The problem with this approach is that experimen-
tal abundances from FAME analysis are neglected, and
simulations always end up choosing lipid species that
cost the least energy, which might not reflect reality, e.g.
if there is regulation in place to ensure production of
longer chain species. Hence, there is need for an ap-
proach that can incorporate both lipid profiling and
FAME analysis, but at the same time can allow flexibility
in the metabolic network.
In this work, we introduce SLIMEr, a method for cor-
rectly representing lipid requirements in GEMs while
allowing network flexibility. The approach adds so-called
SLIME reactions, which split lipids into their basic
components; and lipid pseudo-reactions, that impose
constraints on both the lipid classes and the acyl chain
distributions. By following this approach, we achieve flux
simulations that respect both the lipid class and acyl
chain experimental distribution, and at the same time
avoid over-constraining the model to only simulate one
lipid distribution. We implemented this approach for the
consensus GEM of Saccharomyces cerevisiae (budding
yeast), a model that has undergone iterative improve-
ments [15, 17–20] and is currently being hosted at
https://github.com/SysBioChalmers/yeast-GEM. We show
that the enhanced model: (i) enforces acyl chain require-
ments while preserving a high degree of network flexibility
and an almost equal metabolic energy demand, (ii) better
predicts specific lipid distributions, and (iii) computes lipid
costs of transitioning between experimental conditions.
Results
Representing lipid constraints with the aid of SLIME
reactions
Flux balance analysis (FBA) [21] is based on the following
assumptions on metabolism: (i) a cell has a metabolic goal,
which we can represent through a mathematical objective
function, (ii) under short timescales there is no accumula-
tion of intracellular metabolites, and (iii) metabolic fluxes
are bounded to physical constraints, such as thermody-
namics and kinetics. Those three assumptions define a
basic FBA problem as followed:
Min cTv
 
S  v ¼ 0
LB≤v≤UB
ð1Þ
where S is the stoichiometric matrix, which contains the
stoichiometric coefficients for all reactions and metabolites,
v is the vector of metabolic fluxes [mmol/gDWh], c is the
objective function vector, and LB and UB are the corre-
sponding lower and upper bounds for each of the fluxes
(some of them based on experimental values). As we
usually wish to simulate growth, a biomass pseudo-reaction
is typically added to the stoichiometric matrix as follows:
proteinþ carbohydrateþ lipidþ RNAþ DNA
þ…→Biomass ð2Þ
where protein, carbohydrate, lipid, etc., are pseudo-
metabolites that are produced from a combination of
metabolic components. For example, protein is produced
from a protein pseudo-reaction:
s1 alaþ s2cysþ s3 aspþ…→protein ð3Þ
where si are the measured abundances [mmol/gDW] of
the corresponding amino acids in yeast. In this study we
focus on the lipid pseudo-reaction, which becomes more
challenging to formulate, because there are so many dif-
ferent individual species. One option is to define an
equivalent reaction to Eq.3 with every single lipid species
[10]; however, as these measurements are not available
for most organisms, the lipid pseudo-reaction is usually
represented as the following instead:
s1 PIþ s2 PCþ s3 TAGþ s4 ERG…→lipid ð4Þ
where PI (phosphoinositol), PC (phosphocholine), TAG
(triglyceride), ergosterol (ERG), etc. represent each of
the lipid classes that exist in the model. Most of them
represent not one but a plurality of different molecules,
each with different combinations of acyl chain lengths
and saturations. Therefore, they are also pseudo-
metabolites that need to be produced in turn by add-
itional pseudo-reactions. These pseudo-reactions can be
constructed either in a restrictive or permissive approach
(Fig. 1). The restrictive approach is to enforce the ex-
perimental FAME distribution to every single specific
lipid species. This can be achieved by creating a generic
acyl chain component [12]:
s1 Acyl CoA 16 : 0ð Þ þ s2 Acyl CoA 16 : 1ð Þ
þ…→Acyl CoA ð5Þ
where the si coefficients are fractions inferred from
FAME data. This generic Acyl – CoA is then used to
form each generic lipid species, forcing then every lipid
class to have the same acyl chain distribution. The latter
is an important limitation of this approach, considering
that the acyl chain distribution can vary significantly
across lipid classes [5].
On the other hand, the permissive approach for build-
ing the pseudo-reactions is to allow any of the specific
lipids to form the generic lipid class [15]. For instance,
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the following set of pseudo-reactions can be defined for
PI:
PI ð16 : 0 − 16 : 1Þ→ s1PI
PI ð16 : 1 − 16 : 1Þ→ s2PI
PI ð16 : 1 − 18 : 1Þ→ s3PI
⋮
ð6Þ
where si can be set to 1 or adapted to represent the cost
of producing each specific lipid. The problem of this ap-
proach is that it disregards the acyl chain distribution,
even if FAME data is available. Therefore, once simula-
tions are computed, the model will always end up prefer-
ring the “cheapest” species to produce in terms of
carbon and energy, usually corresponding to species
with the shortest acyl chains, unless the si coefficients
are arbitrarily tuned to favor longer chains.
Additionally, even though for some specific species
such as ergosterol the measured abundance [mg/gDW]
can be directly transformed to the stoichiometric coeffi-
cient in Eq.4 [mmol/gDW], for most lipids the measured
abundance cannot be directly converted, as the molecu-
lar weight varies between specific lipid species. Hence,
average molecular weights need to be estimated in both
permissive and restrictive approaches, leading to skewed
predictions.
In this study we solve all the problems presented
above through two new types of pseudo-reactions, to
account for both constraints on lipid classes and on acyl
chains. The first pseudo-reactions Split Lipids Into
Measurable Entities and are hence referred to as SLIME
reactions. As the name suggests, these pseudo-reactions
take each specific lipid and split it into its basic compo-
nents, i.e. its backbone and acyl chains:
Li j→ si Bi þ
X
k∈ j
s jk Ck ð7Þ
where Lij is a lipid of class i and chain configuration j, Bi
the corresponding backbone, Ck the corresponding chain
k, and si and sjk the associated stoichiometry coefficients.
These reactions replace any pseudo-reaction of the sort
of Eq.5 or Eq.6 that were already present in the model
(Fig. 1).
The second type of pseudo-reactions are new lipid
pseudo-reactions, which will in turn replace Eq.4, the
old lipid pseudo-reaction that only constrained lipid
classes. There are now three different lipid pseudo reac-
tions (Fig. 1): the first pulls all backbone species created
in Eq.7 into a generic backbone and uses the corre-
sponding abundance data [g/gDW] as stoichiometric
coefficients. The second reaction does the same but for
the specific acyl chains, with data from FAME analysis
[g/gDW], to create a generic acyl chain. Finally, the third
reaction merges back together the generic backbone and
the generic acyl chain into a generic lipid, which will be
used in the biomass pseudo-reaction as in Eq.2.
Fig. 1 Overview of the process of including SLIME reactions and new lipid pseudo-reactions for a hypothetical model of three lipid classes and
two types of acyl chain. The active fluxes after simulating the models are highlighted in light blue, showing that a GEM with a restrictive
approach would use the same acyl chain composition for all lipid classes (left upper corner), a GEM with a permissive approach would always
choose the cheapest species from each lipid class (left lower corner), and a GEM with SLIME reactions would satisfy both the lipid class and the
acyl chain distribution, but choosing freely which specific lipid species to produce for this goal (right side)
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For the new reactions to be consistent, we need to
choose adequate stoichiometric coefficients for Eq.7. If
the abundance data would be molar, si would be equal
to 1 and sjk would be equal to the number of repetitions
of the corresponding acyl chain k in lipid j. However, as
the abundance data often comes in mass units, si must
be equal to the molecular weight [g/mmol] of the full
lipid, and sjk must be equal to the molecular weight of
the corresponding acyl chain k, multiplied by the num-
ber of repetitions of k in configuration j. By choosing
these values we allow the SLIME reactions to convert
the molar production of the lipid [mmol/gDWh] into a
mass basis [g/gDWh], which in turn will be converted to
a lipid turnover [1/h] by the lipid pseudo reactions.
Improved model of yeast
We implemented SLIMEr in the consensus
genome-scale model of yeast version 7.8.0 [22], a
model which used the previously mentioned permissive
approach, and had at the start 2224 metabolites and
3496 reactions. Out of those reactions, 176 corre-
sponded to reactions of the sort of Eq.6, which were re-
placed by 186 SLIME reactions that cover in total 19
lipid classes and 6 different acyl chains. An additional 27
metabolites (including both specific and generic back-
bones and acyl chains) and 15 reactions (including trans-
port reactions, lipid pseudo-reactions and exchange
reactions) were added to the model, and 10 metabolites
and 1 reaction (connected to previously deleted reac-
tions) were removed. The final enhanced model had
therefore 2241 metabolites and 3520 reactions, and kept
the number of genes and gene-reaction rules constant,
as only pseudo-reactions with no gene-reaction rules
were modified.
For the reference model, we used both lipid profiling
and FAME data at low growth rate and no stress condi-
tions [23]. The lipid profile was rescaled to be propor-
tional to the FAME data, as detailed in the methods
section. We can see that by using SLIMEr, the enhanced
model was enforced to follow the acyl chain distribution
of the experimental data (Fig. 2a), whereas the previ-
ous permissive model predicted mostly acyl chains of
16-carbon length (less costly), and only a small amount
of 18-carbon length to satisfy the requirement of ergos-
terol ester (Additional file 1: Figure S1), as ergosteryl
oleate is cheaper to produce mass-wise than ergosteryl
palmitoleate (Additional file 1: Table S1).
With the enhanced model we also studied in how
many ways lipid requirements can be satisfied spending
the same amount of energy, by performing flux variabil-
ity analysis (FVA) (Fig. 2b). Comparing these predictions
to the ones of the permissive model (Additional file 1:
Figure S1), we saw some reductions in variability, coming
mostly from changes in phosphatidylcholine and triglyceride
content. However, despite the additional constraints
imposed, lipid metabolism could still rearrange itself
in a wide amount of combinations, and overall flux
variability did not decrease significantly (Additional
file 1: Figure S2a). This agrees with experimental ob-
servations that lipid metabolism is highly flexible [5];
therefore, handling lipid metabolism with SLIME re-
actions is preferred over alternative approaches, such
as models that constrain single individual lipid species [10,
24], as the latter limit the organism to only one feasible
state of lipid metabolism and hence bias results.
Model predictions of specific lipid distributions
To validate model predictions, we used reported data [5]
including measurements of 102 specific lipid species.
This data was added up to compute the totals of each
lipid class and each acyl chain, and these sums were in
turn used as input for creating both a permissive and an
enhanced model. In the latter case, as a total lipid abun-
dance of 8% was assumed, the acyl chain abundances
were rescaled to be proportional to the lipid classes
abundances (see the methods section for more details).
We then performed random sampling of fluxes for the
resulting models, to generate 10,000 specific lipid distri-
butions for each model and for each of the 8 conditions
of the study.
A
B
Fig. 2 The enhanced GEM with improved constraints on lipid
metabolism. a By using SLIMEr, a correct acyl chain composition is
enforced. b Breakdown of the acyl chain distribution and variability
predicted by the enhanced GEM, for each experimentally detected
lipid class. Thick black lines correspond to parsimonious FBA
predictions, while the FVA allowed ranges are shown with
colored bars
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Comparing these in silico lipid distributions to the
original in vivo measurements (Fig. 3a), the enhanced
model improved the average prediction error for all ex-
perimental conditions (Additional file 1: Table S2), and
overall the simulated lipid distributions came much
closer to the experimental values compared to the per-
missive model (Fig. 3b). Furthermore, simulations with
the enhanced model are also superior to simulations
with a restrictive model, as the latter approach would
not capture the fact that many lipid classes show prefer-
ence towards few acyl chains. Instead, it would force the
model to produce all acyl chains in the same proportion
for each lipid class, significantly lowering the quality of
predictions (Additional file 1: Figure S3).
It should be noted that even though SLIMEr improved
the model’s lipid composition predictions, many other
distributions are still predicted to be equally likely for all
simulated conditions (Fig. 3b, Additional file 1: Figure
S4); which reinforces the previously mentioned idea of a
highly flexible lipid network. Furthermore, the fact that
yeast picks a certain lipid distribution in vivo for each
strain and condition, but has many additional options in
silico, points also to a high level of regulation in place to
adapt the distribution of lipid species in S. cerevisiae de-
pending on the genetic background and environmental
conditions [25].
Energy costs at increasing levels of stress
As a final study, we used lipid data of yeast grown under
9 different stress levels [23] to create both a permissive
and enhanced GEM for each of those conditions. We
then computed the differences in ATP turnover and car-
bon requirements between the permissive and enhanced
model, which correspond to the extra energy and carbon
A
C
Fig. 3 Using experimental data to validate the model and predict energy costs. a The lipid composition of 10,000 simulations of the enhanced
model achieved with random sampling are presented for each specific lipid species (blue circles), compared to the actual measured experimental
values (red bars). b Principal component analysis of all (log transformed) lipid abundance distributions for both the permissive (yellow) and enhanced
(blue) models, compared to experimental values (red). Different tonalities of yellow and blue indicate the 8 different simulated conditions and strains. c
Carbon costs (continuous lines) and ATP costs (segmented lines) of satisfying the acyl chain distribution at four increasing levels of temperature (30, 33,
36 and 38 °C), NaCl concentrations (0, 200, 400 and 600mM) and EtOH concentrations (0, 20, 40 and 60 g/L)
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costs, respectively, required to achieve the given acyl
chain distribution in each condition (Fig. 3c). As increas-
ing stress levels are associated to an increase in mainten-
ance energy (Additional file 1: Figure S5) [26], by using
SLIMEr we therefore showed an increase in lipid ex-
penses when transitioning from a metabolic state of low
energy demand to high energy demand.
In the case of the reference condition, the permissive
model could produce 145.9 μmol (ATP)/gDW more than
the enhanced model. Also in this condition, the simulated
growth-associated ATP maintenance (GAM) without
accounting for known polymerization costs of proteins,
carbohydrates, RNA and DNA [27] was of 36.96mmol
(ATP)/gDW, which corresponds to the maintenance costs
of unspecified functions in the model, such as protein
turnover, maintenance of membrane potentials, etc. The
ATP cost for achieving correct acyl chain distribution
under reference conditions corresponded then to 0.4% of
the total costs of processes not included in the model.
This is a rather low percentage, which shows that the
addition of SLIME reactions will not cause a significant
increase in the overall metabolic energy demand, while
making the simulated fluxes in lipid metabolism better
match experimentally observed distributions (Fig. 3b).
Discussion
As previously mentioned, we did not see a significant re-
duction in flux variability of predictions compared to the
permissive approach (Additional file 1: Figure S2). This is
partly explained as in each simulation we maximize the
ATP maintenance; therefore, simulations of the permissive
model (which did not have constraints on the acyl chain
distribution) had a slightly higher ATP maintenance,
making simulations overall similarly constrained. None-
theless, the main advantage of using SLIMEr is not to
constrain simulations more, but instead to constrain lipid
fluxes such that they better match biologically feasible
distributions (Fig. 3b).
It is also important to note that the model does not
take other physiological properties into account, such as
specific regulation, or curvature and fluidity of mem-
branes as function of lipid composition and/or
temperature. It only takes FAME analysis and lipid profile
data, and demonstrates that specific lipid distributions
from simulations are consistent with these measurements.
It would be of interest to account for additional data and
processes such as the ones mentioned, but this is beyond
the scope of this study.
Even though developed for the consensus GEM of S.
cerevisiae, this approach can be extended to any other
model and/or organism. The main challenge here is to
map all lipids in the model to the corresponding
pseudo-metabolites (backbones and chains), as conven-
tions for naming lipids vary a great deal between
different databases and models. Introduction of stan-
dardized metabolite ids [28, 29] can significantly aid this
otherwise laborious task.
Conclusion
With SLIMEr we can now correctly represent biomass
requirements from lipid metabolism in genome-scale
metabolic models. The approach allows the model to
satisfy at the same time requirements on the lipid class
and acyl chain distributions, which is a significant
improvement compared to only being able to constrain
lipid classes [15, 16]. We have also shown the high de-
gree of flexibility in lipid metabolism, which shows that
approaches that over-constrain the lipid requirements by
enforcing specific concentrations for individual species
[10, 11, 24] or forcing a given acyl chain distribution to
all species [12, 13] are not suitable for handling this
flexibility. Finally, we have demonstrated the use of the
expanded model as a tool to compute lipid requirements
in varying experimental conditions. We expect the
enhanced model to be useful for metabolic engineering
applications, particularly for designing strains that can
rearrange the chain length distribution of specific lipid
classes [30].
Methods
Data used
All data used in this study was collected from literature.
For the initial model analysis and the analysis of lipid
metabolism under increasing levels of stress, aerobic
glucose-limited chemostat data of S. cerevisiae, strain
CEN.PK113-7D, growing on minimal media at a growth
rate of D = 0.1 h− 1 was used [23]. The mentioned study
collected lipid abundance data in mg/gDW for both lipid
classes and acyl chains for 1 reference condition plus 9
different conditions of stress (temperature, ethanol and
osmotic stress). Additionally, carbohydrate, protein and
RNA content [g/gDW] was measured for all stress con-
ditions, together with flux data [mmol/gDWh] for glu-
cose and oxygen uptake, and glycerol, acetate, ethanol,
pyruvate, succinate and CO2 production.
For model predictions of specific lipid distributions,
we used published data of S. cerevisiae grown aerobically
on SD media at maximum growth rate (shake flask cul-
tures), under 8 different conditions: four different
BY4741 strains (a wildtype plus three knockout strains),
each cultivated at both 24 °C and 37 °C [5]. In that study,
the authors introduced a novel quantification method
for detecting the abundance of up to 250 singular spe-
cies of lipids. Out of those, 102 were used in our study,
as they had direct correspondence to a species in the
GEM employed. Even though not all lipids were
accounted for in the model, those 102 species included
the ones most abundant in vivo, as such providing high
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mass-coverage (on average 84% of the total detected
lipid abundance) without having to add any additional
lipid species and reactions to the model. Abundance
values were converted from mol/mol to mg/gDW as-
suming an 8% lipid abundance in biomass [23] and con-
sidering the unmatched lipid percentage previously
mentioned. Additionally, we assumed a protein compos-
ition of 0.5 g/gDW, an RNA composition of 0.06 g/gDW,
a glucose uptake of 20.4mmol/gDWh, and biomass
growth rate of 0.41 h− 1, based on previous batch simula-
tions of the yeast GEM [31].
Model enhancement details
The consensus genome-scale model of yeast, version
7.8.0 [22], was used. Compared to version 7.6 from the
published paper [20], the model included a manual cur-
ation detailed in previous work [31], a clustered biomass
pseudo-reaction, and metabolite formulas added to every
lipid. Combining this model together with the experi-
mental data, the following five steps were followed to
create a model with SLIME reactions, specific to each
experimental condition:
1. Add pseudo-metabolites representing each specific
backbone, each specific acyl chain, the generic
backbone and the generic acyl chain.
2. Add for each specific lipid species a SLIME
reaction. These reactions replace the previous ones
of the sort of Eq.6 in the model [15].
3. Add all three new lipid pseudo-reactions (Fig. 1)
using the experimental data [g/gDW]. These reac-
tions replace the original lipid pseudo-
reaction (Eq.4).
4. Scale either the lipid class or the acyl chain
abundance data so that they are proportional, as the
approach is based on exact mass balances. For this,
an optimization problem is carried out where the
coefficients of the corresponding pseudo-reaction
are rescaled to minimize to zero the excretion of
unused backbones and acyl chains (Additional file 1:
Figure S6).
5. Finally, scale any other component in the biomass
pseudo-reaction for which there is data, and ensure
that the biomass composition adds up to 1 g/gDW
[32] by rescaling the total amount of carbohydrates,
which was not measured in the datasets employed.
To compare the performance of the new enhanced
model, an additional model for each condition was cre-
ated, which did not have the acyl chain pseudo-reaction,
but instead exchange reactions for each acyl chain, so
that the model could freely choose the acyl chain distri-
bution. Note that by doing this, the only remaining lipid
constraint is the lipid backbone pseudo-reaction,
meaning that this alternative model is equivalent to the
permissive approach mentioned in the results section.
Therefore, we refer to this model as the “permissive”
model, and use it to benchmark our analysis. In turn, a
comparison to a “restrictive” model is only briefly out-
lined when predicting specific lipid distributions, as the
experimental data showed that the acyl chain distribu-
tion in yeast varies considerably across lipid classes
(Additional file 1: Figure S7), making the restrictive ap-
proach not applicable here.
Simulation details
For all FBA simulations, measured exchange fluxes were
used to constrain the model, allowing up to a 5% of
deviation from the average measurements, and a parsi-
monious FBA approach [33] was followed, maximizing
first the ATP turnover and then minimizing the total
sum of absolute fluxes, in order to find the most com-
pact solution. The obtained ATP turnover value is equal
to the sum of the growth associated ATP maintenance
(GAM) and the non-growth counterpart (NGAM, equal
to 0.7 mmol/gDWh in the original model), and it was
used to compare ATP costs from transitioning from one
state to another.
The variability of each different lipid species was com-
puted with FVA [34] on each corresponding group of
SLIME reactions at a time; e.g., for assessing the variability
of C18:0 in PI, FVA was applied on all SLIME reactions
producing PI and any C18:0 acyl chains. Variability was also
assessed with optGpSampler, an implementation of the arti-
ficial centering hit-and-run algorithm for random sampling
of metabolic fluxes [35]. Abundances in mg/gDW of each
lipid species were then computed from the corresponding
SLIME reaction fluxes, multiplied by the molecular weight
and divided by the biomass growth rate. All simulations
were performed in Matlab® R2018a, using the COBRA
toolbox [36], and Gurobi® 7.5 set as optimizer.
Additional file
Additional file 1: Supplementary material, including all supplementary
tables and supplementary figures. (PDF 1090 kb)
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